Tricida Receives $30,000,000 Series B Financing

  • Feed Type
  • Date
    3/5/2015
  • Company Name
    Tricida
  • Mailing Address
    7000 Shoreline Court South San Francisco, CA 94080 USA
  • Company Description
    Tricida, Inc. is an innovative startup company focused on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular disease.
  • Website
    http://www.tricida.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Tricida’s clinical lead candidate, TRC101, is on track for an IND submission later this year. I am excited by our rapid progress that has allowed us to advance TRC101 from discovery into development in record time.
  • M&A Terms
  • Venture Investor
  • Venture Investor